A joint study by Duchesnay and PeriPharm exposes critical gaps in access to innovative women's health products in Canada
The research reveals the challenges of introducing innovative medications in women's health in Canada
BLAINVILLE, QC, May 29, 2025 /CNW/ - Duchesnay, member of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life Sciences Innovation Award by ADRIQ, in collaboration with PeriPharm, is proud to announce the results of a landmark study exploring the accessibility of innovative women's health products in Canada. The research exposes systemic gaps and significant barriers that prevent Canadian women from accessing the innovative therapies they need.
The study found that of the 45 women's health products approved by the U.S. Food and Drug Administration (FDA) from January 1, 2003, to December 31, 2023, only 24 (53%) had received regulatory approval by Health Canada as of July 2024 and only 13 of these products are currently reimbursed publicly. 1
"These findings highlight a clear need to address inequities in how women's health is assessed, valued and prioritized," said Dany Hallé, Vice president, Commercial Affairs, DPG. "Striving to shape women's health ecosystem in Canada, we, at Duchesnay, believe that Canadian women deserve to have timely access to healthcare innovations."
Another important issue highlighted by researchers is the delays Canadian women face when it comes to approval and reimbursement processes for women's health therapies. Compared to the general access timeline for medications in Canada, the process for obtaining public coverage listing for women's health medications takes one year longer and can even exceed three years.
The study suggests that the current evidence-based Health Technology Assessment (HTA) framework may not fully capture the added value of innovative drugs in women's health, potentially contributing to delays or barriers in reimbursement and market access.
"This is a call to action," said Catherine Beauchemin, Ph.D., partner at PeriPharm. "This initiative marks an important first step toward improving access to innovations in women's health. To advance women's health outcomes in Canada, we must start by understanding their needs and preferences."
This study will serve as a benchmark and lay the groundwork for the development of a position paper co-written by leading experts in the domain addressing the challenges women ultimately face in the assessment of innovative medicines in Canada. This white paper would be hopefully available by year end.
1 In comparison, based on data between 2016 and 2020, 67% of all new active substance approval by FDA and/or EMA have been submitted to Health Canada.
ABOUT PERIPHARM
Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company's mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm's activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives.
For more information about PeriPharm, please visit https://peripharm.com/en/.
Follow us on LinkedIn.
ABOUT DUCHESNAY
Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women's health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.
Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally.
For more information about Duchesnay, please visit https://duchesnay.com/en/.
Follow us on LinkedIn.
ABOUT DUCHESNAY PHARMACEUTICAL GROUP
Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women's health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.
DPG is one of the eight companies across the country chosen to participate in the Government of Canada's Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.
DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG's healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec's research and innovation ecosystem.
DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women's health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
4 hours ago
- Cision Canada
Update on the Canadian Food Inspection Agency's actions at an HPAI infected premise at a British Columbia ostrich farm Français
OTTAWA, ON, May 30, 2025 /CNW/ - The Canadian Food Inspection Agency (CFIA) and Canada's national poultry sectors have been responding to detections of highly pathogenic avian influenza (HPAI) in Canada since December 2021. Industry has been highly supportive of the CFIA in its response to HPAI, working collaboratively to implement control measures and protect animal health. The CFIA has acted to minimize the risk of the virus spreading within Canadian flocks and to other animals. All avian influenza viruses, particularly H5 and H7 viruses, have the potential to infect mammals, including humans. Our disease response aims to protect public and animal health, minimize impacts on the domestic poultry industry, and the Canadian economy. The CFIA's response to highly pathogenic avian influenza in domestic poultry is based on an approach known as "stamping-out", as defined by the World Organisation for Animal Health (WOAH) Terrestrial Animal Health Code. Stamping-out is the internationally recognized standard and is a primary tool to manage the spread of HPAI and mitigate risks to animal and human health as well as enable international trade. It includes steps to eliminate the virus from an infected premises, including the humane depopulation and disposal of infected animals, and disinfection of premises. There are ongoing risks to animal and human health and Canada's export market access Allowing a domestic poultry flock known to be exposed to HPAI to remain alive means a potential source of the virus persists. It increases the risk of reassortment or mutation of the virus, particularly with birds raised in open pasture where there is ongoing exposure to wildlife. CFIA's National Centre for Foreign Animal Disease (NCFAD) identified that the current HPAI infection in these ostriches is a novel reassortment not seen elsewhere in Canada. This assortment includes the D1.3 genotype, which has been associated with a human infection in a poultry worker in Ohio. A human case of H5N1 in BC earlier this year required critical care, and an extended hospital stay for the patient, and there have been a number of human cases in the United States, including a fatality. Stamping-out and primary control zones enable international trade as it allows Canada to contain outbreaks within a specific area, meet the requirements of zoning arrangements with trading partners, and permit Canada's poultry industry to export from disease-free regions. Continued export market access supports Canadian families and poultry farmers whose livelihoods depend on maintaining international market access for $1.75 billion in exports. Current status of the infected premise at Universal Ostrich Farm Universal Ostrich Farm has not cooperated with the requirements set out under the Health of Animals Act including failure to report the initial cases of illness and deaths to the CFIA and failure to adhere to quarantine orders. Universal Ostrich Farm was issued two notices of violations with penalty, totaling $20,000. The farm also failed to undertake appropriate biosecurity risk mitigation measures such as limiting wild bird access to the ostriches, controlling water flow from the quarantine zone to other parts of the farm, or improving fencing. These actions significantly increase the risk of disease transmission and reflect a disregard for regulatory compliance and animal health standards. Universal Ostrich Farm has not substantiated their claims of scientific research. CFIA has not received any evidence of scientific research being done at the infected premises. Research documentation was not provided during the review of their request for exemption from the disposal order based on unique genetics or during the judicial review process. Further, the current physical facilities at their location are not suitable for controlled research activities or trials. On May 13, 2025, the Federal court dismissed both of Universal Ostrich Farm's applications for judicial review. The interlocutory injunction pausing the implementation of the disposal order was also vacated. Following the May 13 court ruling, the farm owners and supporters have been at the farm in an apparent attempt to prevent the CFIA from carrying out its operations at the infected premises. This has delayed a timely and appropriate response to the HPAI infected premises, resulting in ongoing health risks to animals and humans. CFIA's next steps at the infected premises Given that the flock has had multiple laboratory-confirmed cases of H5N1 and the ongoing serious risks for animal and human health, and trade, the CFIA continues planning for humane depopulation with veterinary oversight at the infected premises. The CFIA takes the responsibility to protect the health of animals and Canadians extremely seriously as we conduct these necessary disease control measures to protect public health and minimize the economic impact on Canada's poultry industry. For more detailed information on the CFIA's continued response to HPAI at this infected premises, please visit our website. The Canadian Food Inspection Agency (CFIA) touches the lives of all Canadians in so many positive ways. Each day, hard-working CFIA employees–including inspectors, veterinarians and scientists–inspect food for safety risks, protect plants from pests and invasive species, and respond to animal diseases that could threaten Canada's national herd and human health. Guided by science-based decision-making and modern regulations, the Agency works tirelessly to ensure access to safe and healthy food in Canada, and support access to international markets for our high-quality agricultural products. To learn more, visit
Global News
11 hours ago
- Global News
10 must-haves for managing menopause symptoms
The Curator independently decides what topics and products we feature. When you purchase an item through our links, we may earn a commission. Promotions and products are subject to availability and retailer terms. From hot flashes to hair thinning, the signs and symptoms of menopause and perimenopause can be challenging. The average age of menopause (which is marked by one year without a period) is 51, and most women are in perimenopause (which can last anywhere from two to 10 years) between the ages of 40 and 50. This phase of life might be natural, but that doesn't mean it's easy. If symptoms are seriously disrupting your day-to-day, be sure to talk to your doctor about treatment options. In the meantime, the right cooling gadgets, sweat-wicking fabrics and brain fog-lifting aromatherapy can all help to make things a little easier. Don't worry, you've got this! For hot flashes MFEESYOB Neck Fan Sometimes a few minutes with a gentle breeze on your neck is all it takes to get your body temperature regulated. Keep this sleek fan stashed in your car, at your desk, or on your bedside table. The stylish, leafless design eliminates the risk of hair tangles and ultra-quiet operation allows you to use it during a camera-off Zoom meeting, while you watch TV, or anytime in between. $38.99 on Amazon Story continues below advertisement For dry skin on the face Vichy Neovadiol Post-Menopause Replenishing Firming Night Cream Switching to a richer cream for bedtime will help to soothe and protect aging skin while you sleep. Look for ingredients like peptides for collagen-supporting benefits, vitamin B3 to help improve texture and signs of hyperpigmentation, and barrier-boosting ceramides. $63.95 on Amazon For night sweats This is J Henley Tee Short Set If hot flashes tend to strike in the middle of the night, you're not alone. Night sweats are one of the most common perimenopause symptoms. But you can boost your chances of staying dry and comfortable through the wee hours by switching to a pair of these made-in-Canada ultra-soft, moisture-wicking PJs. $159 at This is J Story continues below advertisement For low energy Scoria Botanicals Cork Yoga Mat This proudly Canadian mat is perfect for yoga, pilates, stretching, or whatever gets your blood pumping. It's made exclusively with cork and tree rubber, making it naturally anti-microbial and odour resistant. Plus, it's so pretty! $134 at Scoria Canada For hair loss BKIND Densifying Hair Serum with Peptides and Turmeric Root Extract Excess shedding and hair thinning is a common symptom of perimenopause and menopause. This serum is packed with amino acids, vitamins, and proteins to nourish the scalp and promote fuller hair. And we loved that BKIND is a woman-founded Canadian brand! $78 at BKIND Story continues below advertisement For dry skin on the body Weleda Skin Food Original Ultra-Rich Body Cream Hormonal fluctuations play starring roles in the health and appearance of your skin below the neck, too. Dry patches and sensitized skin are common during this life phase, but luckily Weleda is known for its thick, rich moisturizers. This body cream contains nourishing plant oils and extracts including rosemary and chamomile to soothe and soften even the driest elbows, shins, knees and feet. $25.99 on Amazon For irritability PURESSENTIEL Stress Roll-On About 4 in 10 women notice mood symptoms during this time—and one of those moods can be irritated (at everyone and everything!). You may also be feeling stressed, sad, or anxious. This little roll-on, containing 12 essential oils, including lavender and chamomile, is designed to take the edge off. $9.99 on Amazon Story continues below advertisement For unpredictable periods Knix Leakproof Cotton High Rise Whether you're spotting frequently or aren't sure when your period might show up next, it's great to have some back-up protection ready. These stylish undies provide superior absorption without any bulk, to keep you comfy and worry-free. $29 at Knix For 3am wake-ups Soundcore Sleep A20 by Anker Wireless Earbuds You may be waking up due to vivid dreams, hot flashes, or with a racing mind. A guided meditation, sleep podcast, or quiet music can be just the thing to ease you back to dreamland and these comfy, highly rated earphones are the ticket. They block noise while providing quality audio and are designed with cushioned wings for side-sleepers. $199.99 on Amazon Story continues below advertisement For weight gain Skechers AERO Spark Midlife weight gain is complicated and can be chalked up to a combination of shifting hormones, metabolic changes, and lifestyle factors. We're not saying you can just walk it off, but moving your body more often will help you manage extra pounds, and regular exercise will give your mental health a boost, too. These innovative sneakers are ultra-cushioned, breathable, and built for logging kms. $195 at Skechers You may also like: SleepPhones Wireless Sleep Headphones – $219.50 JISULIFE Handheld Mini Fan – $18.99 Story continues below advertisement Queen Size 4 Piece Sheet Set – $29.99 2 Pack Journal Notebook – $19.99 Calm Subscription – $14.99 – $399.99
Winnipeg Free Press
12 hours ago
- Winnipeg Free Press
Winds push smoke from Canadian wildfires south into US and compromise air quality
Air quality in some parts of the United States is being compromised as smoke from dozens of wildfires in Canada travels south, pushed by winds high in the atmosphere. Air quality in Arrowhead, Minnesota, is deemed unhealthy for people and animals sensitive to pollution and other airborne particles, according to the Environmental Protection Agency's AirNow page. Moderate air quality is being reported across other parts of northeastern Minnesota, northern Wisconsin, the Chicago area, southwestern Michigan and the state's eastern Upper Peninsula, northern Indiana and western Ohio. Over the next day or so, particulates from the burning trees, leaves and other vegetation could reach further south into Oklahoma, Tennessee and Arkansas, said Patrick Ayd, a meteorologist with the National Weather Service in Duluth, Minnesota. What is AQI and who is at risk? The Air Quality Index — AQI — measures how clean or polluted the air we breathe is on a daily basis. The index focuses on the health effects that might be experienced within a few hours or days after breathing polluted air. AQI is calculated based on ground-level ozone, particle pollution or particulate matter, carbon monoxide, sulfur dioxide, and nitrogen dioxide. Ground-level ozone and airborne particles are the two pollutants that pose the greatest threat to human health in this country. The index ranges from green, where the air quality is satisfactory and air pollution poses little or no risk, to maroon, which is considered hazardous. That level comes with health warnings of emergency conditions where everyone is more likely to be affected, according to AirNow. On Friday morning, the AQI showed orange around the Arrowhead, Minnesota, area, which Ayd said is a concern for people with chronic conditions, the elderly and young children. 'They really should limit their time outdoors,' he added. The level below orange is yellow and considered moderate, where the air quality is acceptable. That is what is showing Friday for some other parts of the Midwest. But fine particle levels are expected to reach the red air quality index in northern Minnesota, a level that is unsafe for everyone, according to the Minnesota Pollution Control Agency. The North Dakota Department of Environmental Quality said it is monitoring air quality levels and advised individuals to limit prolonged outdoor activities. To limit exposure to unhealthy air quality, people should stay indoors with windows and doors closed. Avoid heavy exertion outdoors, using fans or swamp coolers that take air from outside, all wood-burning appliances, and lighting candles and incense. Where are the Canadian wildfires? Nearly two dozens wildfires were burning in the Canadian province of Manitoba, which is just north of Minnesota and North Dakota. So far this year, the province had had more than 100 wildfires. On Wednesday, Manitoba declared a state of emergency as the fires forced 17,000 people to evacuate homes in several communities. Canada's wildfire season runs May through September. Its worst-ever wildfire season was in 2023. It choked much of North America with dangerous smoke for months. 'We are getting the smoke,' said Kevin Doom, meteorologist with the National Weather Service in Chicago. 'The winds way up in the atmosphere — 10,000, 20,000 feet up — are blowing in from the north today. Minnesota is kind of taking the brunt at the moment.' 'The wind is going to drag that smoke down over the next day or two,' Doom added. Doom said a little haze was showing Friday morning over Chicago. 'It will keep moving with the wind,' he continued. 'But over time, it will continue to disperse, mix in with the air until it gets thinner and thinner until it fades away.' Past wildfires and air quality Last summer, fires burning in California, Oregon, Arizona, Washington and other western states, as well as Canada, filled the skies in regions of the western U.S. with smoke and haze, forcing some affected areas to declare air quality alerts or advisories. Two years ago, smoky air from wildfires in Canada also shrouded broad swaths of the U.S. and prompted warnings for people to stay inside. ___________________ Williams reported from Detroit. Raza reported from Sioux Falls, South Dakota.
